PPARGC1B and depressive disorder: Furthermore, in our analysis, several DE miRNA targets were found to be associated with neuropsychiatric disorders, such as schizophrenia (TTN, SYNPO) [48,49], depressive disorder (PPARGC1B, TIMELESS) [50,51,52], and autism (TAF1, TRIO) [53,54].